Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis

KM Mustian, CM Alfano, C Heckler, AS Kleckner… - JAMA …, 2017 - jamanetwork.com
Importance Cancer-related fatigue (CRF) remains one of the most prevalent and
troublesome adverse events experienced by patients with cancer during and after therapy …

Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia

S Peixoto da Silva, JMO Santos… - Journal of cachexia …, 2020 - Wiley Online Library
Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal
muscle mass, along with adipose tissue wasting, systemic inflammation and other metabolic …

[HTML][HTML] Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment

A Fabi, R Bhargava, S Fatigoni, M Guglielmo… - Annals of …, 2020 - Elsevier
Fatigue is the most common symptom experienced by patients during the cancer trajectory
from diagnosis to the end of life and is defined as a distressing, persistent, subjective sense …

[HTML][HTML] Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized …

CM Dieli-Conwright, KS Courneya… - Breast Cancer …, 2018 - Springer
Background Exercise is an effective strategy to improve quality of life and physical fitness in
breast cancer survivors; however, few studies have focused on the early survivorship period …

Cancer-related fatigue, version 2.2015

AM Berger, K Mooney, A Alvarez-Perez… - Journal of the National …, 2015 - jnccn.org
Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical,
emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment …

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study

TS Bekaii-Saab, FS Ou, DH Ahn, PM Boland… - The lancet …, 2019 - thelancet.com
Background Regorafenib confers an overall survival benefit in patients with refractory
metastatic colorectal cancer; however, the adverse event profile of regorafenib has limited its …

Cancer-related fatigue—mechanisms, risk factors, and treatments

JE Bower - Nature reviews Clinical oncology, 2014 - nature.com
Fatigue is one of the most common adverse effects of cancer that might persist for years after
treatment completion in otherwise healthy survivors. Cancer-related fatigue causes …

[HTML][HTML] Effectiveness of a three-week inpatient pulmonary rehabilitation program for patients after COVID-19: a prospective observational study

MC Hayden, M Limbach, M Schuler, S Merkl… - International journal of …, 2021 - mdpi.com
For COVID-19 patients who remain symptomatic after the acute phase, pulmonary
rehabilitation (PR) is recommended. However, only a few studies have investigated the …

Executive leadership and physician well-being: nine organizational strategies to promote engagement and reduce burnout

TD Shanafelt, JH Noseworthy - Mayo Clinic Proceedings, 2017 - Elsevier
These are challenging times for health care executives. The health care field is experiencing
unprecedented changes that threaten the survival of many health care organizations. To …

[HTML][HTML] Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline …

JE Bower, K Bak, A Berger, W Breitbart… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose This guideline presents screening, assessment, and treatment approaches for the
management of adult cancer survivors who are experiencing symptoms of fatigue after …